๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

9158 A phase III study of erlotinib as maintenance therapy in NSCLC to delay progression following first-line chemotherapy (SATURN)

โœ Scribed by Cappuzzo, F.; Coudert, B.; Wierzbicki, R.; Park, K.; Custers, F.; Curbera, G.A.; Giaccone, G.; Hilbe, W.; Klingelschmitt, G.; Ciuleanu, T.


Book ID
122880307
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
48 KB
Volume
7
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


6600 POSTER A Randomized, Multicenter, O